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ABSTRACT
Objectives: To investigate olfaction in general
population, prevalence of olfactory dysfunction and
related risk factors.
Design: Cross-sectional population-based survey,
distributing four microencapsulated odorants (rose,
banana, musk and gas) and two self-administered
questionnaires (odour description; epidemiology/health
status).
Setting: The survey was distributed to general
population through a bilingual (Catalan, Spanish)
newspaper in Catalonia (Spain), on December 2003.
Participants: Newspaper readers of all ages and
gender; 9348 surveys were analysed from the 10 783
returned.
Main outcome measures: Characteristics of
surveyed population, olfaction by age and gender, smell
self-perception and smell impairment risk factors.
Terms normosmia, hyposmia and anosmia were used
when participants detected, recognised or identified all
four, one to three or none of the odours, respectively.
Results: Survey profile was a 43-year-old woman with
medium–high educational level, living in a city. Olfaction
was considered normal in 80.6% (detection), 56%
(recognition/memory) and 50.7% (identification).
Prevalence of smell dysfunction was 19.4% for
detection (0.3% anosmia, 19.1% hyposmia), 43.5% for
recognition (0.2% anosmia, 43.3% hyposmia) and
48.8% for identification (0.8% anosmia, 48%
hyposmia). Olfaction was worse (p<0.0001) in men
than in women through all ages. There was a significant
age-related smell detection decline however smell
recognition and identification increased up to fourth
decade and declined after the sixth decade of life. Risk
factors for anosmia were: male gender, loss of smell
history and poor olfactory self-perception for detection;
low educational level, poor self-perception and
pregnancy for recognition; and older age, poor self-
perception and history of head trauma and loss of smell
for identification. Smoking and exposure to noxious
substances were mild protective factors for smell
recognition.
Conclusions: Sense of smell in women is better than
in men suggesting a learning process during life with
deterioration in older ages. Poor self-perception, history
of smell loss, head trauma and pregnancy are potential
risk factors for olfactory disorders.
INTRODUCTION
The sense of smell provides information on
the surrounding environment, warns us about
chemical dangers and putrid food and may
even help people to mate. Smell disorders may
affect the ability to enjoy food and aromas
while interfering with the ability to notice
potentially harmful chemicals and gases.1
In 1987, the National Geographic Smell
Survey (NGSS) studied a large US sample
population (1.2 million) whereby 1% of
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participants could not smell three or more of six odor-
ants using a ‘scratch and sniff’ test.2 Age was an import-
ant factor in smell deterioration and smell was rated
better in women than in men. In 1994, the National
Health Interview Survey3 reported data from 42 000 USA
households with 1.4% prevalence of self-reported olfac-
tory dysfunction, exponentially increasing with age. This
study, however, did not include any testing of smell
function.
The prevalence and associated risk factors of olfactory
impairment in the European population has been inves-
tigated to a limited extent. In the Swedish version of the
NGSS,4 done in 532 individuals older than 45 years,
increasing age was associated with impaired ability to
detect/identify odorants, with no effect of gender on
smell perception. Education has also been shown to
account for a signiﬁcant portion of the age-related vari-
ance in identiﬁcation.5 Another European population-
based study identiﬁed a signiﬁcant relationship between
impaired olfaction and aging, male gender and nasal
polyps, but not with diabetes or smoking, reporting an
olfactory dysfunction prevalence of 19.1%.6
Approximately two-thirds of smell dysfunction cases are
likely due to prior upper respiratory infections, head
trauma or sinonasal diseases.7 Toxic chemical exposure,
epilepsy, pollution, drugs, nutritional disturbances and
neurodegenerative diseases may also cause olfactory dis-
orders.8 9 Smoking may cause a reversible reduction in
the ability to smell10 11 while chronic rhinosinusitis/nasal
polyps may result in a partial or total loss of smell.12
The aims of this study were to investigate the status of
olfaction in the general population while determining
the prevalence of olfactory dysfunction and its related
risk factors.
METHODS
Study design
The OLFACAT (Olfaction in Catalonia) survey was
carried out in the general population of Catalonia in
Spain. Two questionnaires, olfaction and demography-
health status and a set of four microencapsulated odor-
ants were distributed in the 250 000 daily issues of the
newspaper El Periódico de Catalunya on 23 December
2003. The survey was presented in both Catalan and
Spanish languages to facilitate the choice of the pre-
ferred language. The present manuscript has followed
the STROBE checklist guidelines.
The study was approved by the Institutional Ethics and
Clinical Research Committee of Hospital Clínic de
Barcelona (reference 1295).
Measurements
Survey odorants
Four common odorants were included in the survey: rose
(2% of Bulgarian rose in 98% of phenyl-ethyl alcohol) as
a ﬂoral odour; banana (amyl-isobutirate at 50% in
dietyl-phtalate) as a food odour; musk (1 : 1 mixture of
galaxolide and diethyl-phtalate exaltolide) as a perfume
odour; and gas (mixture of 30% mercaptan and 70% tet-
rahydrothiophene) as an industrial odour. Each com-
pound was prepared following established formulas and
the solution magnetically homogenised. Rose, banana
and musk odorants were elaborated by Antonio Puig SA
(Barcelona, Catalonia, Spain) and gas odorant by
ENAGAS (Saragossa, Spain). Stability test protocols were
performed by accelerating the olfactory aging of products
at 40°C for 2 months, following their smell evolution
after 1–8 weeks. The microencapsulation process was
done by ARCADE Europe (Paris, France) as follows:
essential oil component was contained and delivered
from highly durable synthetic microcapsules manufac-
tured using a proprietary polycondensated polymerisa-
tion method. The microcapsules were blended with a
water-based polymer adhesive to form printable slurry.
Odorants were adhered to a smell-less paper and dis-
patched using a folded-form design so as to prevent
direct contact between odour samples.
Smell questionnaire
Participants were asked to scratch and sniff each odour
and then answer three questions: ﬁrst, odour detection:
did you smell any scent? (yes, no); second, odour recog-
nition/memory: have you ever smelt this scent? (yes,
no) and third, forced-choice odour identiﬁcation: which
name deﬁnes the scent you have smelt?, whereby only
one of the four given options was correct. The term
‘normosmia’ was used when a participant was able to
detect, recognise (memory) or correctly identify all four
tested odours; the term ‘hyposmia’ was used when a par-
ticipant was not able to detect, recognise (memory) or
correctly identify one, two or three tested odours and
the term ‘anosmia’ was used when a participant was
unable to detect, recognise (memory) or correctly iden-
tify any of the four tested odours.
Epidemiological and health-status questionnaire
From the 12-question questionnaire, four questions were
on demography: ﬁrst, gender (men and women);
second, age (years); third, current educational level
(primary school, secondary school, high school,
University or College) and fourth, residential area (city
and postcode). Two questions described smell self-
perception: ﬁfth, how do you consider your current sense
of smell? (very good, good, poor and very poor) and
sixth, have you ever lost the sense of smell? (never, up to
1 week and over 1 week). Two questions were on expos-
ure to toxic or noxious substances: seventh, have you ever
been exposed to dust, gases, fumes, vapours or/and vola-
tile toxics at home and/or at work? (yes, no) and eighth,
do you smoke? (no, exsmoker and smoker). Two ques-
tions were on health-status: ninth, have you ever had a
severe face and/or head trauma? (yes, no) and 10th,
have you ever been diagnosed with chronic rhinosinusi-
tis? (yes, no). Finally, two questions were on women’s
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health: 11th, are you currently pregnant? (yes, no); and
12th, are you currently menstruating? (yes, no).
Data management and statistical analysis
The returned surveys were read using an optical system
(BV Scan system, Voxpublica), the data were transferred
to an electronic database, and then statistically analysed
using Stata V.8 (Stata Statistical Software: Release 8.0
College Station, Texas, USA: Stata Corporation 2003).13
The data-cleaning process was based on programmed
queries to identify records containing inconsistent or
uncertain data. The corrupt or inaccurate values identi-
ﬁed by these queries were subsequently recorded as
missing values in the data set.
Only those surveys fully and consistently answered
were considered for statistical analysis. Differences
between gender in epidemiological and health-status
characteristics were evaluated by χ2 test (table 4).
Adjusted (multivariate) logistic regression models for
anosmia and hyposmia were estimated (tables 1–3). To
estimate the multivariate models for anosmia, the covari-
ates that do not have any events (anosmia cases) in any
of its categories were not included. Results from esti-
mated models were expressed as adjusted OR and 95%
CI. The reference category used to calculate the OR for
each level of variables measured on an ordinal scale was
the immediately previous category, starting with the
second. Results from estimated models were expressed
as OR and 95% CI. All tests were performed using a two-
tailed signiﬁcance level of 0.05.
RESULTS
Characteristics of the surveyed population
Following the data cleaning process, 5.6% of answers from
the 10 783 received surveys were identiﬁed as inconsistent.
After the exclusion of both these inconsistent question-
naire returns and the incomplete epidemiological and
health-status questionnaires (7.7%), the sample size for
analysis was 9348 questionnaires (ﬁgure 1).
Age and gender
The mean age of the surveyed population was 43.3 years,
ranging from 5 to 91 years. The analysis was performed
in seven age groups to ensure a reasonable sample size
for each age and gender group. Almost two-thirds of
participants were women (65.7%), of which 2.1% were
pregnant and 12.7% were menstruating (table 4).
Education and residential zone
Most participants (83.8%) had a high educational level
(high school or University/College) and were living
(93.9%) in an urban area, with no differences between
genders (table 4).
Exposure to tobacco and noxious substances
More than one-ﬁfth (21.4%) of participants were
smokers, 28.3% were exsmokers, while almost a third
(29.9%) reported to be regularly exposed to toxic or
noxious substances, either at home or at work. Men
reported a higher exposure to both tobacco smoke
(24.8%, p<0.0001) and noxious substances (33.9%,
p<0.0001) than women (19.7% and 27.7%, respectively)
(table 4).
Health status
In total, 4.4% of participants had received a diagnosis of
chronic rhinosinusitis, with similar prevalence in women
and men, while 5% reported a history of face/head
trauma, this prevalence being higher in men than in
women (6.2% vs 4.3%, p<0.0001) (table 4).
Sense of smell
All four odours (normosmia) were detected by 80.6%,
recognised by 56%, and identiﬁed by 50.7% of the sur-
veyed population. One to three odours (hyposmia) were
detected by 19.1%, recognised by 43.3% and identiﬁed
by 48%. None of the four odours (anosmia) were
detected by 0.3%, recognised by 0.2% and identiﬁed by
0.8%. Individual odours were more highly detected
(rose 99.4%, banana 98.9%, gas 96.9% and musk 84.4%)
than recognised (rose 94.8%, banana 96.2%, gas 94.9%
and musk 66.2%) or correctly identiﬁed (rose 91.8%,
banana 89.8%, gas 92.1% and musk 65.4%). Moreover,
individual odours were always better detected, recognised
and identiﬁed by women than by men, except for rose
and banana recognition.
Smell by gender and age
Within the population experiencing normosmia, there
was a signiﬁcant and progressive age-related decline of
smell detection while smell recognition and identiﬁca-
tion increased up to the fourth decade of life, continued
to plateau throughout the ﬁfth and sixth decades, and
declined thereafter. Signiﬁcant but opposite ﬁndings
were found for hyposmia and anosmia.
Normosmia was higher in women than in men
(p<0.0001) either in smell detection (82.8% vs 76.5%),
recognition/memory (58% vs 51.9%) or identiﬁcation
(54.1% vs 44.3%; ﬁgure 2). Hyposmia was higher in men
than in women (p<0.0001) either in smell detection
(22.8% vs 17.1%), recognition/memory (47.1% vs
41.4%) and identiﬁcation (54% vs 44.9%; ﬁgure 3).
Finally, anosmia was higher in men than in women in
both smell detection (0.9% vs 0.1%; p<0.0001) and iden-
tiﬁcation (1.2% vs 0.6%; p=0.0057), but not in smell rec-
ognition/memory (0.2% vs 0.2%, p=0.9569; ﬁgure 4). In
the oldest group (over 70 years), the prevalence for
anosmia of detection (4.4%) and identiﬁcation (6.6%)
was especially higher in men than in women (0% and
1.4%, respectively; ﬁgure 4).
Smell self-perception
Subjective description of smell
Regardless of gender and age, 93.1% of participants sub-
jectively rated their sense of smell as good or very good,
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Table 1 Distribution and relative risk for hyposmia (smell of one to three odours) or anosmia (smell of none of the four odours) in the case of smell detection using a multivariate
logistic analysis of demographic and health problems
Covariable Hyposmia (detection) Anosmia (detection)
8601 Subjects, 1639 with hyposmia (19%) 9251 Subjects, 25 with anosmia (0.3%)
No Yes Adjusted OR (95% CI) p Value No Yes Adjusted OR (95% CI) p Value
Female 4686 (67.3%) 967 (59.0%) 0.78 (0.69 to 0.88) <0.0001 6077 (65.9%) 7 (28.0%) 0.22 (0.07 to 0.71) 0.0111
Educational level*
Elementary school 23 (0.3%) 7 (0.4%) – – 0.0352 32 (0.3%) 0 (0.0%) – – –
Middle school 1061 (15.2%) 247 (15.1%) 0.76 (0.32 to 1.81) 1436 (15.6%) 8 (32.0%) – –
High school 3053 (43.9%) 683 (41.7%) 1.02 (0.86 to 1.21) 4020 (43.6%) 11 (44.0%) – –
University 2825 (40.6%) 702 (42.8%) 1.18 (1.05 to 1.34) 3738 (40.5%) 6 (24.0%) – –
Subjective description of sense of smell*
Very good 1563 (22.5%) 275 (16.8%) – – <0.0001 1968 (21.3%) 2 (8.0%) – – <0.0001
Good 4990 (71.7%) 1167 (71.2%) 1.24 (1.08 to 1.44) 6636 (71.9%) 2 (8.0%) 0.20 (0.03 to 1.48)
Poor 388 (5.6%) 188 (11.5%) 1.94 (1.58 to 2.37) 608 (6.6%) 5 (20.0%) 9.69 (1.58 to 59.30)
Very poor 21 (0.3%) 9 (0.5%) 0.75 (0.33 to 1.70) 14 (0.2%) 16 (64.0%) 109.54 (30.51 to 393.35)
Loss of smell history*
Never 4829 (69.4%) 1130 (68.9%) – – 0.0935 6429 (69.7%) 5 (20.0%) – – 0.0172
≤1 week 1796 (25.8%) 384 (23.4%) 0.88 (0.78 to 1.01) 2324 (25.2%) 1 (4.0%) 0.71 (0.08 to 6.35)
>1 week 337 (4.8%) 125 (7.6%) 1.25 (0.97 to 1.62) 473 (5.1%) 19 (76.0%) 9.26 (0.98 to 87.07)
Exposure to noxious
substances
2023 (29.1%) 491 (30.0%) 1.02 (0.91 to 1.16) 0.7025 2749 (29.8%) 9 (36.0%) 2.00 (0.67 to 5.92) 0.2117
Chronic rhinosinusitis 296 (4.3%) 75 (4.6%) 0.99 (0.76 to 1.30) 0.9662 410 (4.4%) 3 (12.0%) 0.59 (0.09 to 3.96) 0.5887
Menstruation 616 (8.8%) 116 (7.1%) 0.97 (0.78 to 1.20) 0.7655 777 (8.4%) 0 (0.0%) – – –
Age (years)*
<20 374 (5.4%) 54 (3.3%) – – <0.0001 441 (4.8%) 1 (4.0%) – – –
20–29 914 (13.1%) 163 (9.9%) 1.12 (0.80 to 1.57) 1118 (12.1%) 1 (4.0%) – –
30–39 1667 (23.9%) 356 (21.7%) 1.17 (0.95 to 1.44) 2150 (23.3%) 0 (0.0%) – –
40–49 1893 (27.2%) 456 (27.8%) 1.14 (0.97 to 1.33) 2514 (27.2%) 2 (8.0%) – –
50–59 1360 (19.5%) 386 (23.6%) 1.17 (1.00 to 1.37) 1909 (20.7%) 7 (28.0%) – –
60–69 528 (7.6%) 162 (9.9%) 1.08 (0.88 to 1.34) 779 (8.4%) 6 (24.0%) – –
>70 226 (3.2%) 62 (3.8%) 0.85 (0.61 to 1.19) 315 (3.4%) 8 (32.0%) – –
Residential zone†
Rural (reference) 121 (1.7%) 31 (1.9%) 1 – 0.0821 165 (1.8%) 0 (0.0%) – – –
Semirural 294 (4.2%) 85 (5.2%) 1.15 (0.72 to 1.83) 403 (4.4%) 1 (4.0%) – –
Urban 6547 (94.0%) 1523 (92.9%) 0.87 (0.58 to 1.30) 8658 (93.8%) 24 (96.0%) – –
Smoking†
Non-smoker
(reference)
3535 (50.8%) 789 (48.1%) 1 – 0.9331 4646 (50.4%) 10 (40.0%) 1 – 0.9608
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while 6.9% of them reported their smell as poor or very
poor, the smell score being better in women than in
men (p<0.0001) (table 4).
Loss of smell history
A history of loss of smell was reported by almost one-third
(30.4%) of participants, predominantly for less than
1 week (25.1%). The smell loss for over 1 week was more
frequent in men (6.4% vs 4.8%, p=0.0042) (table 4).
Risk factors for smell impairment
Smell detection
Women detected odours more frequently than men
(82.8% vs 76.5%, p<0.0001). The risk for anosmia of
detection was lower in women (OR=0.22) and higher in
subjects reporting a loss of smell history for over 1 week
(OR=9.26); and anosmia was also associated with a worse
smell self-perception (table 1). The risk for hyposmia of
detection was lower in women (OR=0.78) and associated
with older age (>50-year-old), a lower educational level
and a worse smell self-perception (table 1).
Smell recognition/memory
Women showed a better capability to recognise odours
than men (58% vs 51.9%; p<0.0001). The risk for
anosmia of recognition was higher in pregnant women
(OR=6.94) and associated with a lower educational level
and a worse smell self-perception (table 2). The risk for
hyposmia of recognition was lower in women (OR=0.79)
and higher in subjects reporting a loss of smell history
for over 1 week (OR=1.23); and it was associated with
older age (>70 years old), a lower educational level, and
a worse smell self-perception. Smoking (both exsmokers
and smokers; OR=0.80 and 0.68, respectively) and fre-
quent contact with noxious substances (OR=0.83) were
found to have a mild but signiﬁcant protective effect on
odour recognition/memory (table 2).
Forced-choice smell identification
Women performed better than men on odour identiﬁca-
tion (54.1% vs 44.3%, p<0.0001). The risk for anosmia
of identiﬁcation was higher in subjects reporting a
history of head trauma (OR=3.38) and a loss of smell for
over 1 week (OR=2.79), and it was associated with older
age (>60 years old) and a worse smell self-perception
(table 3). The risk for hyposmia of identiﬁcation was
lower in women (OR=0.76) and higher in subjects
reporting a loss of smell history for over 1 week
(OR=1.28), and it was associated with older age
(>60-year-old), a lower educational level and a smell
worse self-perception (table 3).
DISCUSSION
The most important ﬁndings of the OLFACAT survey
were: ﬁrst, the overall prevalence of olfactory dysfunction
in the case of detection was 19.4%, with a total loss of
smell (anosmia) of 0.3%. Despite this high prevalence of
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Table 2 Relative risk for hyposmia (smell of one to three odours) or anosmia (smell of none of the four odours) in the case of smell recognition/memory using a multivariate logistic
analysis of demographic characteristics and health problems
Covariable Hyposmia (recognition/memory) Anosmia (recognition/memory)
6778 Subjects, 2936 with hyposmia (43%) 9079 Subjects, 18 with anosmia (0.2%)
No Yes Adjusted OR (95% CI) p Value No Yes Adjusted OR (95% CI) p Value
Female 2663 (69.3%) 1885 (64.2%) 0.79 (0.71 to 0.88) <0.0001 5986 (66.1%) 12 (66.7%) 1.26 (0.41 to 3.81) 0.6879
Educational level*
Elementary school 14 (0.4%) 14 (0.5%) – – 0.0200 31 (0.3%) 2 (11.1%) – – 0.0005
Middle school 536 (14.0%) 505 (17.2%) 1.20 (0.56 to 2.60) 1387 (15.3%) 4 (22.2%) 0.05 (0.01 to 0.29)
High school 1671 (43.5%) 1272 (43.3%) 0.84 (0.72 to 0.97) 3942 (43.5%) 11 (61.1%) 1.18 (0.34 to 4.08)
University 1621 (42.2%) 1145 (39.0%) 0.93 (0.83 to 1.04) 3701 (40.8%) 1 (5.6%) 0.09 (0.01 to 0.73)
Subjective description of sense of smell*
Very good 961 (25.0%) 532 (18.1%) – – <0.0001 1939 (21.4%) 3 (16.7%) – – 0.0039
Good 2690 (70.0%) 2164 (73.7%) 1.45 (1.28 to 1.64) 6510 (71.8%) 12 (66.7%) 1.13 (0.31 to 4.10)
Poor 187 (4.9%) 234 (8.0%) 1.62 (1.30 to 2.01) 600 (6.6%) 1 (5.6%) 0.75 (0.08 to 7.40)
Very poor 4 (0.1%) 6 (0.2%) 0.98 (0.26 to 3.66) 12 (0.1%) 2 (11.1%) 65.35 (4.60 to 927.55)
Loss of smell history*
Never 2620 (68.2%) 2087 (71.1%) – – 0.0020 6303 (69.6%) 11 (61.1%) – – 0.7159
≤1 week 1050 (27.3%) 685 (23.3%) 0.81 (0.73 to 0.91) 2299 (25.4%) 4 (22.2%) 1.22 (0.38 to 3.91)
>1 week 172 (4.5%) 164 (5.6%) 1.23 (0.95 to 1.59) 459 (5.1%) 3 (16.7%) 1.76 (0.23 to 13.60)
Exposure to noxious
substances
1201 (31.3%) 803 (27.4%) 0.83 (0.74 to 0.93) 0.0010 2694 (29.7%) 4 (22.2%) 0.58 (0.18 to 1.82) 0.3497
Chronic rhinosinusitis 168 (4.4%) 127 (4.3%) 1.02 (0.80 to 1.30) 0.8574 404 (4.5%) 1 (5.6%) 0.72 (0.08 to 6.40) 0.7720
Menstruation 347 (9.0%) 249 (8.5%) 1.08 (0.90 to 1.29) 0.4244 774 (8.5%) 1 (5.6%) 1.14 (0.13 to 9.87) 0.9070
Age (years)*
<20 175 (4.6%) 214 (7.3%) – – <0.0001 437 (4.8%) 1 (5.6%) – – 0.7500
20–29 494 (12.9%) 405 (13.8%) 0.80 (0.62 to 1.03) 1108 (12.2%) 1 (5.6%) 1.06 (0.06 to 18.62)
30–39 956 (24.9%) 663 (22.6%) 0.81 (0.68 to 0.96) 2115 (23.3%) 4 (22.2%) 1.29 (0.14 to 11.82)
40–49 1088 (28.3%) 689 (23.5%) 0.91 (0.79 to 1.04) 2475 (27.3%) 2 (11.1%) 0.46 (0.08 to 2.66)
50–59 775 (20.2%) 564 (19.2%) 1.06 (0.92 to 1.24) 1881 (20.8%) 3 (16.7%) 1.74 (0.28 to 10.81)
60–69 268 (7.0%) 257 (8.8%) 1.22 (0.99 to 1.50) 755 (8.3%) 4 (22.2%) 1.84 (0.37 to 9.12)
>70 86 (2.2%) 144 (4.9%) 1.64 (1.19 to 2.26) 290 (3.2%) 3 (16.7%) 1.73 (0.35 to 8.63)
Residential zone†
Rural (reference) 73 (1.9%) 49 (1.7%) 1 – 0.4187 164 (1.8%) 0 (0.0%) – – –
Semi-rural 157 (4.1%) 139 (4.7%) 1.27 (0.82 to 1.96) 390 (4.3%) 2 (11.1%) – –
Urban 3612 (94.0%) 2748 (93.6%) 1.10 (0.76 to 1.59) 8507 (93.9%) 16 (88.9%) – –
Smoking†
Non-smoker
(reference)
1857 (48.3%) 1648 (56.1%) 1 – <0.0001 4567 (50.4%) 12 (66.7%) – – –
Exsmoker 1081 (28.1%) 766 (26.1%) 0.80 (0.71 to 0.91) 2537 (28.0%) 6 (33.3%) – –
Smoker 904 (23.5%) 522 (17.8%) 0.68 (0.60 to 0.78) 1957 (21.6%) 0 (0.0%) – –
History of head
trauma
201 (5.2%) 134 (4.6%) 0.86 (0.68 to 1.08) 0.1917 446 (4.9%) 0 (0.0%) – – –
Pregnancy 60 (1.6%) 35 (1.2%) 0.84 (0.55 to 1.29) 0.4243 125 (1.4%) 1 (5.6%) 6.94 (0.74 to 65.52) 0.0907
Data presented as adjusted OR, 95% CI.
*OR relative to the previous category.
†OR relative to the reference category.
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Table 3 Relative risk for hyposmia (smell of one to three odours) or anosmia (smell of none of the four odours) in the case of forced-choice smell identification using a multivariate
logistic analysis of demographic characteristics and health problems
Covariable Hyposmia (identification) Anosmia (identification)
8107 Subjects, 3894 with hyposmia (48%) 9195 Subjects, 75 with anosmia (1%)
No Yes Adjusted OR (95% CI) p Value No Yes Adjusted OR (95% CI) p Value
Female 2911 (69.1%) 2368 (60.8%) 0.76 (0.69 to 0.84) <0.0001 6008 (65.9%) 38 (50.7%) 0.96 (0.55 to 1.67) 0.8850
Educational level*
Elementary school 8 (0.2%) 18 (0.5%) – – 0.0007 31 (0.3%) 0 (0.0%) – – –
Middle school 654 (15.5%) 608 (15.6%) 0.49 (0.21 to 1.16) 1419 (15.6%) 24 (32.0%) – –
High school 1881 (44.6%) 1636 (42.0%) 1.01 (0.88 to 1.15) 3970 (43.5%) 28 (37.3%) – –
University 1670 (39.6%) 1632 (41.9%) 1.21 (1.09 to 1.34) 3700 (40.6%) 23 (30.7%) – –
Subjective description of sense of smell*
Very good 1034 (24.5%) 667 (17.1%) – – <0.0001 1948 (21.4%) 8 (10.7%) – – <0.0001
Good 2979 (70.7%) 2841 (73.0%) 1.42 (1.27 to 1.58) 6567 (72.0%) 38 (50.7%) 1.27 (0.59 to 2.76)
Poor 183 (4.3%) 374 (9.6%) 2.06 (1.69 to 2.51) 592 (6.5%) 13 (17.3%) 2.16 (1.00 to 4.66)
Very poor 17 (0.4%) 12 (0.3%) 0.26 (0.12 to 0.56) 13 (0.1%) 16 (21.3%) 36.06 (13.12 to 99.13)
Loss of smell history*
Never 2895 (68.7%) 2741 (70.4%) – – 0.0005 6361 (69.7%) 38 (50.7%) – – 0.0415
≤1 week 1130 (26.8%) 901 (23.1%) 0.82 (0.74 to 0.91) 2301 (25.2%) 12 (16.0%) 0.93 (0.48 to 1.81)
>1 week 188 (4.5%) 252 (6.5%) 1.28 (1.02 to 1.62) 458 (5.0%) 25 (33.3%) 2.79 (1.14 to 6.88)
Exposure to noxious
substances
1255 (29.8%) 1132 (29.1%) 0.98 (0.89 to 1.08) 0.6930 2716 (29.8%) 23 (30.7%) 1.03 (0.60 to 1.77) 0.9111
Chronic rhinosinusitis 187 (4.4%) 170 (4.4%) 0.96 (0.77 to 1.20) 0.7290 403 (4.4%) 5 (6.7%) 0.80 (0.28 to 2.29) 0.6824
Menstruation 390 (9.3%) 304 (7.8%) 1.03 (0.87 to 1.22) 0.7157 772 (8.5%) 2 (2.7%) 0.49 (0.11 to 2.14) 0.3421
Age (years)*
<20 203 (4.8%) 194 (5.0%) – – <0.0001 438 (4.8%) 3 (4.0%) – – 0.0006
20–29 551 (13.1%) 466 (12.0%) 0.82 (0.64 to 1.04) 1106 (12.1%) 8 (10.7%) 0.76 (0.19 to 2.96)
30–39 1032 (24.5%) 839 (21.5%) 0.94 (0.80 to 1.10) 2131 (23.4%) 11 (14.7%) 0.65 (0.25 to 1.68)
40–49 1198 (28.4%) 1004 (25.8%) 1.05 (0.93 to 1.19) 2490 (27.3%) 10 (13.3%) 0.68 (0.28 to 1.65)
50–59 822 (19.5%) 831 (21.3%) 1.20 (1.05 to 1.37) 1886 (20.7%) 12 (16.0%) 1.40 (0.58 to 3.38)
60–69 302 (7.2%) 371 (9.5%) 1.19 (0.99 to 1.43) 763 (8.4%) 17 (22.7%) 3.38 (1.51 to 7.55)
>70 105 (2.5%) 189 (4.9%) 1.43 (1.07 to 1.91) 306 (3.4%) 14 (18.7%) 1.24 (0.51 to 3.01)
Residential zone†
Rural (reference) 76 (1.8%) 71 (1.8%) 1 – 0.3585 162 (1.8%) 1 (1.3%) 1 – 0.9858
Semi-rural 176 (4.2%) 181 (4.6%) 1.11 (0.75 to 1.65) 400 (4.4%) 3 (4.0%) 0.87 (0.08 to 8.95)
Urban 3961 (94.0%) 3642 (93.5%) 0.95 (0.68 to 1.33) 8558 (93.8%) 71 (94.7%) 0.85 (0.12 to 6.21)
Smoking†
Non-smoker
(reference)
2118 (50.3%) 1968 (50.5%) 1 – 0.5326 4594 (50.4%) 30 (40.0%) 1 – 0.2814
Exsmoker 1169 (27.7%) 1131 (29.0%) 0.96 (0.86 to 1.07) 2567 (28.1%) 30 (40.0%) 1.61 (0.88 to 2.93)
Smoker 926 (22.0%) 795 (20.4%) 0.94 (0.83 to 1.06) 1959 (21.5%) 15 (20.0%) 1.41 (0.70 to 2.82)
History of head
trauma
204 (4.8%) 193 (5.0%) 0.97 (0.79 to 1.20) 0.7963 442 (4.8%) 12 (16.0%) 3.38 (1.69 to 6.74) 0.0006
Pregnancy 62 (1.5%) 48 (1.2%) 1.02 (0.69 to 1.51) 0.9157 126 (1.4%) 1 (1.3%) 1.72 (0.22 to 13.33) 0.6017
Data presented as adjusted OR, 95% CI.
*OR relative to the previous category.
†OR relative to the reference category.
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smell impairment, only 6.9% of the subjects considered
having a poor or very poor sense of smell. Second, there
was a signiﬁcant age-related decline in smell detection
for both genders. However, cognitive smell (recognition
and identiﬁcation) was increased and/or was maintained
up to the sixth decade of life, declining thereafter. Third,
besides women having a better self-perception of smell
capabilities than men, women also scored better than
men in smell detection, recognition and identiﬁcation,
and did so throughout their lifetime. Fourth, pregnancy,
but not menstruation was associated with a partial loss
(hyposmia) of smell recognition. Fifth, male gender,
poor smell self-perception, low educational level and
ageing, but not chronic rhinosinusitis, were risk factors
related to smell impairment whether in terms of detec-
tion, recognition or identiﬁcation. Subjects with a history
of persistent olfactory loss or head trauma were also at
higher risk of smell impairment. Sixth, ﬁnally and surpris-
ingly, persistent exposure to noxious substances and
smoking showed to be protective factors for cognitive
smell impairment in either recognition or identiﬁcation.
Approximately 6.4 million Catalans, 39.5 million
Spaniards and 425 million European Union (EU) citi-
zens are aged 15 years or older, according to Catalan,
Spanish and European Statistic Institutes. Our survey
therefore estimates that 1.2 million adult Catalans, 7.7
million Spaniards and over 82 million EU citizens suffer-
ing from olfactory dysfunction, of which 20 000
Catalans, 120 000 Spaniards and 1.5 million EU citizens
have a total loss of sense of smell.
Brämerson et al6 reported an overall prevalence of
olfactory impairment of 19.1% in a Swedish population
which was very similar to our 19.4%. This prevalence is
considerably higher than self-reported loss of smell in
the NGSS2 (1.4%) and in our own survey where 6.9% of
participants were considered to have a poor or very poor
sense of smell, suggesting a low sensitivity for the sub-
jective assessment of smell loss. The fact that many
people may be unaware of their smell dysfunction, espe-
cially the elderly and/or those living alone, implies an
increased risk for both nutritional problems14 and safety
in the face of a potential domestic ﬁre or gas leak.15
In accordance with the OLFACAT survey data, previous
studies have indicated that sense of smell detection is
impaired with ageing, even in healthy individuals16 and
from the second to the eighth decade of life.17 Our data
also align with the NGSS and other studies in that the
age decline in odour perception is universal across sub-
jects regardless of gender odorants, outcome measures,
or cultural diversity.2 6 Smell changes observed across
the survey’s age span are similar to a previous study
reporting a progressive decline in odour.18 Concerning
cognitive smell (memory and identiﬁcation), we
observed an increase in performance in the ﬁrst
decades of life, reaching a plateau during the third
through to ﬁfth decades of life and declining thereafter.
Larsson et al4 reported that age was associated with an
increased ability to identify banana odour (amylacetate).
Our survey, in agreement with the NGSS ﬁndings, found
not only an increased ability to recognise and identify
Figure 1 Flow-chart of participants in the OLFACAT (Olfaction in Catalonia) survey.
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banana, but rose and gas also, with increase indicated
up to the ﬁfth decade of life but decreasing thereafter.
Due to the fact that repeated exposure to odorants and
olfactory training may increase olfactory identiﬁcation
skills without modifying odour detection,18 these
age-increased abilities for smell identiﬁcation but not
for detection, could be explained by the acquisition of
cognitive smell skills through learnt experience.
Among the potential mechanisms proposed for
age-related olfactory loss are the replacement of olfac-
tory mucosa with respiratory epithelium caused by
disease or pollutant exposure,19 cribiform plate calciﬁca-
tion,20 olfactory bulb atrophy,21 decreased number of
glomeruli/mitral cells in the olfactory tract22 and/or
volume loss in temporal lobe areas.23
In accordance with other studies,2 6 8 our survey
found that women performed better in olfactory tasks
compared with men of the same age group as well as
self-reporting a better perception of smell sense. This
gender difference was maintained across the lifespan,
and increased considerably after the seventh decade of
life. However, other studies have not found gender dif-
ferences in olfactory sensitivity and identiﬁcation,
although women were slightly better.4 We have to note
that the rates of correctly identiﬁed odours (54.1% by
women, 44.3% by men) are lower than those found in
the Barcelona Smell Test (BAST)-24 validation,24 in
which the present survey is based, and a potential
explanation could be that the OLFACAT study was done
in the general population, with both healthy and
Table 4 OLFACAT (Olfaction in Catalonia) epidemiological characteristics and gender comparison: age, women’s health,
education level, smoking and toxic exposure, subjective description of smell, residential zone, history of head trauma, chronic
rhinosinusitis and loss of smell history
Male, N (%) Female, N (%) Total, N (%) p Value
Population characteristics* 3211 (34.3) 6137 (65.7) 9348 (100)
Age (years)*
<20 127 (3.9) 315 (5.1) 442 (4.7) <0.0001†
20–29 241 (7.5) 878 (14.3) 1119 (12.0)
30–39 668 (20.8) 1487 (24.2) 2155 (23.1)
40–49 861 (26.8) 1673 (27.3) 2534 (27.1)
50–59 766 (23.9) 1181 (19.3) 1947 (20.8)
60–69 355 (11.1) 454 (7.4) 809 (8.6)
>70 193 (6.0) 149 (2.4) 342 (3.7)
Menstruation* 781 (12.7)
Pregnancy* 128 (2.1)
Educational level*
Elementary school 7 (0.2) 26 (0.4) 33 (0.3) <0.0001†
Secondary school 508 (15.8) 978 (15.9) 1486 (15.9)
High school 1505 (46.9) 2568 (41.9) 4073 (43.6)
University/college 1191 (37.1) 2565 (41.8) 3756 (40.2)
Smoking*
Non-smokers 1185 (36.9) 3513 (57.2) 4698 (50.3) <0.0001†
Ex-smokers 1231 (38.3) 1418 (23.1) 2649 (28.3)
Smoker 795 (24.8) 1206 (19.7) 2001 (21.4)
Subjective description of sense of smell*
Very good 407 (12.7) 1576 (25.7) 1983 (21.2) <0.0001†
Good 2472 (77.0) 4243 (69.1) 6715 (71.9)
Poor 315 (9.8) 305 (5.0) 620 (6.6)
Very poor 17 (0.5) 13 (0.2) 30 (0.3)
Residential zone*
Rural 57 (1.8) 109 (1.8) 166 (1.8) 0.9535†
Semirural 142 (4.4) 263 (4.3) 405 (4.3)
Urban 3012 (93.8) 5765 (93.9) 8777 (93.9)
History of head trauma* 200 (6.2) 264 (4.3) 464 (5.0) <0.0001†
Exposure to noxious substances* 1090 (33.9) 1703 (27.7) 2793 (29.9) <0.0001†
Chronic rhinosinusitis* 137 (4.3) 277 (4.5) 414 (4.4) 0.5814†
Loss of smell history*
Never 2217 (69.0) 4289 (69.9) 6506 (69.6) 0.0042†
≤1 week 789 (24.6) 1555 (25.3) 2344 (25.1)
>1 week 205 (6.4) 293 (4.8) 498 (5.3)
*Number of subjects (percentage).
†χ2 test.
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diseased participants, when in the BAST-24 validation all
participants were healthy.
Interestingly, our survey found than pregnancy but not
menstruation was associated with a lack of odour recog-
nition/memory. Changes in odour perception during
pregnancy have been investigated in small studies and
with controversial ﬁndings,25 with olfactory dysfunction
being more linked to changes in nasal sensitivity than in
real smell perception.26 Clearly but not signiﬁcantly, our
survey showed that women had an increased risk for
anosmia of smell recognition/memory during preg-
nancy (n=125, OR=6.94).
In addition to male gender and ageing, we found that
a history of transient olfactory loss for more than 1 week
was associated to impairment in odour detection, recog-
nition and identiﬁcation. Postviral olfactory dysfunction
has been found among the common causes of olfactory
disorders of which spontaneous recovery might occur
within 2 years.21 27
Moreover, survey participants with a history of head
trauma had a higher risk of anosmia in the forced-
choice identiﬁcation task. One of the major causes of
smell dysfunction, affecting all ages, is traumatic brain
injury, secondary to a partial or total damage of olfactory
bulbs and tracts. This can involve frontal and temporal
brain poles, as anosmia usually correlated with trauma
severity.28
Although severe chronic rhinosinusitis with nasal
polyps usually has a negative impact on smell function,12
our data did not identify chronic rhinosinusitis as being
a risk factor for the loss of smell. This controversial
ﬁnding, also described in other surveys,26 may be due
Figure 3 Evolution of hyposmia (smell of one to three odours) during lifetime. For detection, hyposmia showed a progressive
increase during the life span, while for recognition/memory and identification hyposmia decreased up to the fourth decade of life,
continued to plateau throughout the fifth and sixth decades and increased thereafter. For detection, recognition/memory or
identification, hyposmia was significantly lower (p<0.0001) in women (blue line) than in men (red line).
Figure 2 Evolution of normosmia (smell of all four odours) during lifetime. Smell detection showed a progressive decrease
during the lifespan, while smell recognition/memory and identification increased up to the fourth decade of life, continued to
plateau throughout the fifth and sixth decades, and declined thereafter. For detection, recognition/memory or identification,
normosmia was significantly higher (p<0.0001) in women (blue line) than in men (red line).
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either to possible mild levels of severity or self-
misdiagnosis of the disease among survey participants.
Studies on the impact of smoking on the sense of
smell are not conclusive, specially when different smell
qualities are considered. Some studies have shown
adverse effects on smell detection, identiﬁcation and
intensity for some odours8 10 11 whereas others have
found no effect on smell detection and discrimination
for other odorants.9 26 29 In our survey, data showed that
smoking might be a mild but signiﬁcant protective
factor for cognitive smell. An explanation for this contra-
dictory ﬁnding could be the activation of subtype-
selective nicotinic receptors in the olfactory bulb. For
instance, in neurodegenerative disorders such as
Parkinson Disease (PD) olfactory loss is being consid-
ered as a signiﬁcant early symptom that correlates with
the progression of disease.30 In addition to the current
evidence for the protective effect of smoking in PD,31
recent studies suggest that therapy with nicotine recep-
tor agonists mediate enhancement of olfactory working
memory in rats32 and could delay the progress of neuro-
degeneration in PD.33 However, further epidemiologic
and mechanistic studies need to be done taking into
account the different smell qualities (detection, memory
and identiﬁcation) to bring deﬁnitive light to the impact
of smoking in the sense of smell.
Another interesting ﬁnding showed that odour per-
formance was positively related to a level of education
superior to primary school. It is known that odour
identiﬁcation and semantic memory proﬁciency tap
the same domain,34 and that educational background
is one of the most important predictors of cognitive
decline with age, with cognitive deﬁcits occurring
earlier and more extensively in people with a low
educational level.35 From an olfactory perspective,
education and training may help to develop a
wider repertoire of cognitive strategies to assist
performance in verbal memory tasks, such as odour
identiﬁcation.36
As with all epidemiological studies, the OLFACAT
survey may have some weaknesses. (1) The survey popu-
lation cannot be considered a random sample since
there was no control over who and how the survey was
performed or whether participants were preferentially
motivated to answer the survey. (2) The survey’s data
may not be fully representative of the general popula-
tion since the readership survey (2003) shows that the
newspaper’s readers belong to a higher socio-cultural
class (85.1% middle class) and have a higher educa-
tional level (31.1% ﬁnished secondary school) than the
general Catalan population (65.0% and 25.6%, respect-
ively, 2002 census). (3) Although other studies have not
found smell differences among different ethnic groups,
the lack of ethnic diversity in our sample (mainly
Caucasians) could limit the generalisation to other
ethnic groups. (4) Cognitive disturbances in elderly
individuals are characterised by impaired smell function
but also potentially accounting for unwillingness to par-
ticipate in the survey. (5) Subjects with smell impair-
ment could have been more/less interested in
participating in the survey leading to an over/underesti-
mation of the prevalence of dysfunction. (6)
Observations were based on cross-sectional data,
making it impossible to disentangle true ageing effects
from cohort membership. (7) The survey could have a
positive female response bias since almost two-thirds of
participants who returned the surveys were women
(65.7%).
In agreement with earlier ﬁndings in other cultures,
the present survey on the general population indicates
an age-related deterioration in odour detection, recog-
nition and identiﬁcation, with a higher prevalence and
a more manifest age decline in men than in women.
Pregnancy, head trauma and a transient olfactory loss
Figure 4 Evolution of anosmia (smell of none of the four odours) during lifetime. Anosmia showed a progressive mild increase
during the life span but being more significant after the sixth decade of life. For detection, recognition/memory or identification,
anosmia was significantly lower (p<0.0001) in women (blue line) than in men (red line), with a maximal difference after the
seventh decade of life.
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history are absolute risk factors for olfactory dysfunc-
tion while having a higher educational level and
smoking may be protective factors for smell. In order
to understand the role of smell in human behaviour
and determine the potential inﬂuence of cognitive,
sensorial and environmental factors, there is however
an obvious need for well-designed longitudinal
population-based studies, which deploy validated smell
tests and consider the characteristics of the populations
studied.
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